Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Human papillomavirus type 18 L1 capsid protein antigen | est un(e) (attribut) | antigène du papillomavirus humain de type 18 | true | Inferred relationship | Some | ||
| Human papillomavirus type 18 L1 capsid protein antigen | est un(e) (attribut) | Antigen of Human papillomavirus L1 capsid protein (substance) | true | Inferred relationship | Some | ||
| Human papillomavirus type 18 L1 capsid protein antigen | est un(e) (attribut) | Protein antigen | false | Inferred relationship | Some | ||
| Human papillomavirus type 18 L1 capsid protein antigen | est un(e) (attribut) | antigène viral | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | True | Human papillomavirus type 18 L1 capsid protein antigen | Inferred relationship | Some | 2 |
| GARDASIL 120 micrograms per 0.5 milliliter suspension for injection Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | True | Human papillomavirus type 18 L1 capsid protein antigen | Inferred relationship | Some | 4 |
| GARDASIL 9 270 micrograms per 0.5 milliliter suspension for injection Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | True | Human papillomavirus type 18 L1 capsid protein antigen | Inferred relationship | Some | 9 |
This concept is not in any reference sets